Literature DB >> 7640822

The effect of pre-hospital administration of intravenous nalbuphine on on-scene times.

G S Johnson1, H R Guly.   

Abstract

The use of intravenous nalbuphine in pre-hospital settings by paramedics has been demonstrated to be safe and effective. We assessed the effect of this additional intervention by comparing the time spent on-scene by ambulance crews treating patients with fractures of the tibia and fibula who received intravenous nalbuphine with those who had placement of an intravenous cannula alone and those who had neither cannula nor nalbuphine. The mean on-scene times were 17.1 min without cannulation, 29.9 min for cannulation without nalbuphine and 37.5 min for cannulation and administration of nalbuphine. The benefits of effective pre-hospital analgesia thus have a cost in terms of time. Continued audit of interventions and on-scene times is important to prevent inappropriate delays in pre-hospital care which may cause clinical and operational problems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640822      PMCID: PMC1342511          DOI: 10.1136/emj.12.1.20

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


  8 in total

1.  Prehospital intravenous nalbuphine administered by paramedics.

Authors:  J A Chambers; H R Guly
Journal:  Resuscitation       Date:  1994-03       Impact factor: 5.262

2.  Is ALS necessary for pre-hospital trauma care?

Authors:  D D Trunkey
Journal:  J Trauma       Date:  1984-01

3.  Panel: prehospital trauma care--stabilize or scoop and run.

Authors:  J R Border; F R Lewis; C Aprahamian; J A Haller; L M Jacobs; A Luterman
Journal:  J Trauma       Date:  1983-08

4.  Do ambulance crews triage trauma patients?

Authors:  A Rouse
Journal:  Arch Emerg Med       Date:  1991-09

5.  Nalbuphine analgesia in the prehospital setting.

Authors:  J K Stene; L Stofberg; G MacDonald; R A Myers; A Ramzy; B Burns
Journal:  Am J Emerg Med       Date:  1988-11       Impact factor: 2.469

6.  Prehospital venous access in an urban paramedic system--a prospective on-scene analysis.

Authors:  P T Pons; E E Moore; J M Cusick; M Brunko; B Antuna; L Owens
Journal:  J Trauma       Date:  1988-10

7.  Basic trauma life support.

Authors:  H A Werman; R N Nelson; J E Campbell; R L Fowler; P Gandy
Journal:  Ann Emerg Med       Date:  1987-11       Impact factor: 5.721

8.  Evaluation of resuscitation from cardiopulmonary arrest by paramedics.

Authors:  G R McSwain; W B Garrison; C P Artz
Journal:  Ann Emerg Med       Date:  1980-07       Impact factor: 5.721

  8 in total
  9 in total

1.  Fluid resuscitation in prehospital trauma care: a consensus view.

Authors:  M Revell; K Porter; I Greaves
Journal:  Emerg Med J       Date:  2002-11       Impact factor: 2.740

2.  Nalbuphine and slow release morphine.

Authors:  Jason Smith; Henry Guly
Journal:  BMJ       Date:  2004-06-12

Review 3.  Evaluation of emergency medical services systems: a classification to assist in determination of indicators.

Authors:  C MacFarlane; C A Benn
Journal:  Emerg Med J       Date:  2003-03       Impact factor: 2.740

4.  On-scene times for trauma patients in West Yorkshire.

Authors:  S W Goodacre; A Gray; A McGowan
Journal:  J Accid Emerg Med       Date:  1997-09

5.  A comparison of glucagon and glucose in prehospital hypoglycaemia.

Authors:  M A Howell; H R Guly
Journal:  J Accid Emerg Med       Date:  1997-01

6.  Effects on patient care of introducing prehospital intravenous nalbuphine hydrochloride.

Authors:  P Hyland-McGuire; H R Guly
Journal:  J Accid Emerg Med       Date:  1998-03

7.  Hitting them where it hurts? Low dose nalbuphine therapy.

Authors:  M Woollard; T Jones; K Pitt; N Vetter
Journal:  Emerg Med J       Date:  2002-11       Impact factor: 2.740

8.  Excessive morphine requirements after pre-hospital nalbuphine analgesia.

Authors:  K P Houlihan; R G Mitchell; A D Flapan; D J Steedman
Journal:  J Accid Emerg Med       Date:  1999-01

9.  [Intraosseous infusion for adults].

Authors:  B A Leidel; C Kirchhoff
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.